An Israeli company is fighting to be the first in the world to make infant formula with cultured breast milk instead of the animal or plant-based substitutes currently on the market.If BioMilk is successful in producing cultured breast milk with the ingredients that exist almost exclusively in In reality, this will be a fundamental change for the infant formula market in particular and the dairy industry in general. It will also play a key role in producing a next generation of healthier adults. Breast milk is the healthiest for babies, according to all studies. Last week, BioMilk said it received approval from the Helsinki Committee to launch new research in collaboration with the Department of Obstetrics, Gynecology and Fertility of the Rabin Medical Center-Beilinson Campus in Petah Tikva. About fifty post-partum volunteers will donate approximately 50 ml. of breast milk, which will be transferred to the company to separate the cells that produce breast milk and use them to produce the main components of breast milk. “Our groundbreaking research with Beilinson Hospital is for us a significant sign of the revolution and changes we intend to bring about in the dairy industry in Israel and around the world,” said Tomer Eisen, CEO of BioMilk, in a press release. “I anticipate that the research results that can be obtained may be the ‘next step’ in the milk substitutes market, which will enable any mother who cannot or does not choose to breastfeed to provide her baby with these. same nutritional values ​​as comes from traditional breast milk. BioMilk’s technology was developed by Professor Nurit Argov-Argaman of the Hebrew University of Jerusalem, who has been working for more than a decade on the process of producing cultured milk from mammary gland cells without them. to milk. This includes cows, sheep, goats, and other mammals.

The engine of his work is better nutrition, Argov-Argaman told The Jerusalem Post. “There is a huge difference between the composition of breast milk and the current commercial formulas on the market,” she said. “There is a huge lack of the ability to truly mimic breast milk, and the health consequences have become well known.” Babies who drink formula as the only food in the first six months of life are more likely than breastfed babies to develop diarrhea and inflammation. short-term and asthma, metabolic syndromes, blood pressure illnesses and even long-term strokes, Argov-Argaman said. “It could be very important for the public health of society,” she said. mothers who do not breastfeed to give breastmilk to their infants go through breastmilk banks, which are generally not regulated, except those which provide milk to neonatal intensive care units and similar facilities . This “safe milk” is very expensive and inaccessible to the average parent. If the study goes well, the goal is to start marketing within the next three years, according to the company’s vice president of business development, Nathaniel Benchemhoun. There are two potentials. paths for BioMilk. The company could first produce the additional ingredients that exist in breast milk, but lack in infant formulas, and combine them into existing formulas, thereby improving the quality of existing milk substitutes on the market. Also, beyond breast milk, the same technology could be used to take advantage of the healthier components of goat and cow’s milk, making milk better for postmenopausal women or young children with allergies, for Par example, Argov-Argaman said, “I want to make milk,” she said. “I want to make super milk… with a much higher positive impact on our health.”